Thymalfasin
11 research papers indexed
Romani 2004 — TLR/MyD88 Mechanism Thymosin
0
Blood
·2004PreclinicalImmune signalingSourcePreclinical
Wu 2013 — ETASS Sepsis Trial
0
Intensive Care Med
·2013RCTHumanSevere sepsisSourceRCT
Yang 2008 — Thymosin Alpha-1 HBV Meta-Analysis
0
Antiviral Res
·2008Meta AnalysisHumanChronic hepatitis BSourceMeta Analysis
Ciancio 2012 — HCV Non-Responder Phase 3
0
Journal of Viral Hepatitis
·2012RCTHumanChronic hepatitis C non-respondersSourceRCT
Goldstein 1977 — Thymosin Alpha-1 Isolation
0
PNAS
·1977PreclinicalFoundational chemistrySourceFoundational
Thymalfasin combined with immune checkpoint inhibitors in treatment of non-small cell lung cancer
0
Pak J Med Sci
·2026Clinical TrialHumanNon-small cell lung cancer
Thymosin α1-induced secretion of IL-15/RA complex by THP-1-derived dendritic cells
0
Virulence
·2026Basic ResearchCellImmune modulation
Thymosin α1 improves outcomes of patients with hepatitis B virus-related acute-on-chronic liver failure
0
Immunopharmacol Immunotoxicol
·2026Clinical TrialHumanHepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF)
Wu 2025 — TESTS Sepsis Trial
0
BMJ
·2025RCTHumanSepsisSourceRCT
Liu 2020 — Thymosin Alpha-1 in COVID-19 Wuhan
0
Clin Infect Dis
·2020RetrospectiveHumanCOVID-19 severe casesSourceCOVID 19
Maio 2010 — Thymosin Alpha-1 in Melanoma
0
J Clin Oncol
·2010RCTHumanMetastatic melanomaSourceRCT